Interaction Guide · Research summary

Can I take Dandelion Root Dry with Canagliflozin?

Review Dandelion Root Dry with Canagliflozin: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

A dehydration or other safety interaction between dried dandelion root and canagliflozin has not been established. Traditional urinary use provides a reason to review the product, not a measured combination risk.

What this answer covers

Dried Taraxacum officinale root, particularly covered decoction preparations; leaf extracts, fresh juice and other formulations differ.

Supplement or preparation
Dandelion Root Dry
Medication ingredient
canagliflozin

Root evidence is preparation-specific

The EMA monograph includes comminuted dried root used as a decoction and traditional urinary-flushing use. It reports no interactions, but that is not proof of safety with every medicine.

The drug can change volume status

Canagliflozin can cause volume depletion. A small clinical study found an early plasma-volume change that largely attenuated over time; it did not test dandelion root.

A traditional diuretic use is not a clinical interaction

The monograph does not quantify an additive diuretic effect with canagliflozin. Leaf studies cannot be substituted for dry root, and a concentrated product may differ from the decoction.

Fit use to the fluid plan

Discuss the root product and any dizziness or fluid-loss illness with the clinician. The root monograph advises against its urinary-use preparations where medical fluid restriction is needed. Do not override a prescribed fluid plan.

Evidence and practical considerations

Side effects & toxicity

Traditional root urinary use plus canagliflozin volume warning does not demonstrate an exact-pair adverse effect; no-interactions-reported is not proof of safety.

Exact scope
Dried Taraxacum officinale root, particularly covered decoction preparations; leaf extracts, fresh juice and other formulations differ. with Oral canagliflozin RxCUI1373458 IN; agent-specific renal and metabolic mechanisms.
Medication form and route
oral medication; oral supplement

What remains uncertain

  • No arbitrary interval, class-only metabolism assumption or unmeasured pair-event rate.

Factors that may matter: Preparation; Dose; Kidney function; Volume status; Other diabetes treatment.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral canagliflozin

SGLT2 inhibition increases urinary glucose. Volume contraction can cause hypotension or acute kidney injury, with risk modifiers. UGT inducers may lower drug exposure and effectiveness. Insulin/secretagogue co-use increases hypoglycemia risk.

How this applies: Exact single-ingredient canagliflozin, not all SGLT2 agents or combination products.

Warnings do not establish every botanical interaction or routine sodium supplementation. Renal function and whole regimen matter.

Source 2: regulatory herbal monograph

ema.europa.eu · Source check Sep 10, 2026

Population: Users of covered dandelion-root preparations

Traditional urinary-flushing use; adequate fluids required, not recommended where fluid restriction advised. No interactions reported.

How this applies: Exact dried root identity and preparation limitations retained.

Traditional use is not a measured diuretic effect or direct canagliflozin safety study. Root not leaf; capsules/extracts may differ.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 36type2diabetes participants.

Early plasma-volume reduction largely attenuated by week12 while urinary glucose effects persisted.

How this applies: Exact canagliflozin and supplement preparation/endpoint boundaries retained.

Small study; volume change is not a proven sodium-pill requirement or herb interaction.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact canagliflozin article separating volume effects, metabolic exposure and intrinsic supplement risks.
Research summary published

Article revision: 6edf6dc75ee5f7fa

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.